Department of Otorhinolaryngology ENT

Medicine & Life Sciences

1. Squamous Cell Carcinoma 100%
2. Neoplasms 57%
3. Pathologic Constriction 55%
4. Recurrence 45%
5. Anaplastic Thyroid Carcinoma 44%
6. Acoustic Neuroma 43%
7. Neck 41%
8. Robotics 34%
9. Zenker Diverticulum 33%
10. Therapeutics 32%
11. Oropharyngeal Neoplasms 30%
12. Radiotherapy 30%
13. Survival 27%
14. Neoplasm Metastasis 26%
15. Head 23%
16. Skull Base 22%
17. Squamous Cell Carcinoma of Head and Neck 22%
18. Neck Dissection 22%
19. Oropharynx 21%
20. Facial Nerve 20%
21. Neurosurgeons 20%
22. Head and Neck Neoplasms 19%
23. Tongue 18%
24. Myotomy 18%
25. Lymph Nodes 17%
26. Thyroid Gland 17%
27. Deglutition Disorders 17%
28. Carcinoma 16%
29. Systematic Reviews 16%
30. Parotid Gland 16%
31. Olfactory Esthesioneuroblastoma 15%
32. Pleomorphic Adenoma 14%
33. Fluorodeoxyglucose F18 14%
34. Trigeminal Neuralgia 14%
35. Thyroid Neoplasms 14%
36. Surgeons 14%
37. Growth mental deficiency syndrome of Myhre 14%
38. Confidence Intervals 14%
39. Dissection 13%
40. Neurilemmoma 13%
41. Meningioma 12%
42. Retrospective Studies 12%
43. Nose 12%
44. Laryngoscopes 12%
45. Free Tissue Flaps 11%
46. Dilatation 11%
47. Length of Stay 11%
48. Microvascular Decompression Surgery 11%
49. Gentamicins 11%
50. Lasers 11%
51. Palatine Tonsil 11%
52. Laryngectomy 10%
53. Hypophysectomy 10%
54. Mouth 10%
55. Hearing 10%
56. Tracheostomy 10%
57. Diverticulum 10%
58. Paraganglioma 10%
59. Positron-Emission Tomography 10%
60. Interleukin-4 Receptors 10%
61. Inclusion Body Myositis 10%
62. Radiosurgery 10%
63. Larynx 10%
64. Angiofibroma 9%
65. Radiation 9%
66. Multicenter Studies 9%
67. Guidelines 9%
68. Trigeminal Nerve 9%
69. Lymphangioma 9%
70. Vertigo 9%
71. Meniere Disease 9%
72. Papillary Thyroid Cancer 9%
73. Partial Epilepsy 9%
74. Melanoma 9%
75. Hearing Loss 9%
76. Airway Obstruction 8%
77. Cohort Studies 8%
78. Laryngoscopy 8%
79. Pituitary Neoplasms 8%
80. Cranial Nerves 8%
81. DNA 8%
82. Cysts 8%
83. T-Lymphocytes 8%
84. Seizures 8%
85. Sella Turcica 8%
86. Polytetrafluoroethylene 8%
87. Drug Resistant Epilepsy 8%
88. Observation 8%
89. Neurosurgical Procedures 7%
90. interleukin 4 (38-37)-PE38KDEL 7%
91. Upper Esophageal Sphincter 7%
92. Airway Management 7%
93. Biopsy 7%
94. Prospective Studies 7%
95. Pathology 7%
96. Morbidity 7%
97. North America 7%
98. Quality of Life 7%